Page 8 - Flipbook

U.S. PLCO (Prostate, Lung, Colorectal, and Ovarian)

Cancer Screening Trial

• 76,685 men aged 55-74 years

• annual screening for 6 years or “usual care”

• median f/u of 13 years by 2009

• The cumulative incidence rate for PCa was slightly higher in the

screened group with no difference in PCa mortality

• More men in the control arm had PSAs

• Younger men benefited from PSA screening